{"id":3626,"date":"2022-09-01T16:30:52","date_gmt":"2022-09-01T08:30:52","guid":{"rendered":"http:\/\/www.sinotau.com\/homepage\/"},"modified":"2024-10-25T09:20:55","modified_gmt":"2024-10-25T01:20:55","slug":"homepage","status":"publish","type":"page","link":"http:\/\/www.sinotau.com\/en\/","title":{"rendered":"Home page"},"content":{"rendered":"\n<section class=\"page page-home-s1\"><video class=\"vid\" src=\"\/wp-content\/uploads\/2024\/05\/\u5148\u901a\u9996\u9875\u89c6\u9891.mp4\" poster=\"\/wp-content\/themes\/qnz\/assets\/img\/banners\/slider01.jpg\" autoplay=\"\" muted=\"\" loop=\"\" webkit-playsinline=\"true\" playsinline=\"true\" x-webkit-airplay=\"allow\" x5-video-player-type=\"h5\" x5-video-player-fullscreen=\"true\" x5-video-orientation=\"portraint\"><\/video><div class=\"txt-container\">\n        <div class=\"container\">    \n          <div class=\"text20\">                        <\/div>\n          <h2 class=\"text60\">Invent radiopharmaceuticals for lives <\/h2>\n          <div class=\"text32 mb-media-3\">Lays out  <strong>oncology , neurology and cardiology<\/strong> <\/div>\n          <div class=\"go\"> <a href=\"http:\/\/www.sinotau.com\/en\/products\/\">Products<i class=\"iconfont icon-right\"><\/i><\/a><\/div>\n        <\/div>\n      <\/div>\n    <\/section>\n\n\n<section class=\"page page-home-s2\">\n<div class=\"row g-0 align-items-center\">\n<div class=\"col-md-6\">\n<div class=\"left_col wow fadeInUp\">\n<div class=\"sub_title\">Who We Are?<\/div>\n<h2 class=\"title text32 mb-media-3\">A company ahead of the innovative radiopharmaceuticals in China.<\/h2>\n<p class=\"des mb-media-3\">Since 2014, Sinotau started the R&amp;D of next-generation radiopharmaceuticals,which is an innovative pharmaceutical company specializing in the R&amp;D, production, clinical application and marketing of radiopharmaceuticals<\/p>\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/about\/\">About Sinotau<\/a><\/div>\n<\/div>\n<\/div>\n<div class=\"col-md-6\">\n<div class=\"right_col wow fadeInUp pt-media-5 pb-media-5\">\n<div class=\"data\">\n<div class=\"row\">\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">9<\/div>\n<p>Year+<\/p>\n<\/div>\n<div class=\"des\">Years of radiopharmaceutical R&amp;D<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">100<\/div>\n<p>%<\/p>\n<\/div>\n<div class=\"des\">Focus on radiopharmaceuticals<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">3<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Products<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">20<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Pipeline<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">5<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">R&amp;D and production sites<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">400<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Skilled employees<\/div>\n<\/div>\n<\/div>\n<div class=\"col-6\">\n<div class=\"item\">\n<div class=\"num\">\n<div class=\"counter\">80<\/div>\n<p>+<\/p>\n<\/div>\n<div class=\"des\">Authorized Patent<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<section class=\"page page-home-s3\">\n<div class=\"row g-0 align-items-lg-center\">\n<div class=\"col-md\">\n<div class=\"bg\">\n<div class=\"pic\"><img decoding=\"async\" src=\"\/wp-content\/themes\/qnz\/assets\/img\/nb_02.jpg\" alt=\"Radiopharmaceutical Structure\" \/>\n<div class=\"dot\" style=\"z-index: 300;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Chelate<\/h4>\n\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 75%; top: 64%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Linker<\/h4>\n\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 85%; top: 65%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Radioisotopes<\/h4>\n<\/div>\n<\/div>\n<div class=\"dot\" style=\"left: 36.5%; top: 85%;\">\n<div class=\"clice wow fadeInUp\">\u00a0<\/div>\n<div class=\"tip\">\n<h4>Targeting Molecule<\/h4>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-md\">\n<div class=\"right_col wow fadeInUp\">\n<div class=\"sub_title\">Innovation<\/div>\n<h2 class=\"title text32\">From precise diagnostics to targeted therapies, we pioneer next-generation solutions helping improve therapeutic outcomes and the lives of patients.<\/h2>\n<p class=\"des\">Sinotau has established differentiated and highly competitive pipeline out of high attention of the R&amp;D innovation and for the sustainable development and theranostic radiopharmaceuticals with the characteristic and diverse innovation ability of our own team.<\/p>\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/innovating\/\">Pipeline<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column page page-home-s4 is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"news-header\">\n<div class=\"row align-items-center mb-media-2\">\n<div class=\"col-md\">\n<div class=\"title-section wow fadeInUp\">\n<h4 class=\"sub_title\">News<\/h4>\n<h3 class=\"title text32\">Sinotau is totally engrossed in research and development of radiopharmaceuticals. Learn about our latest progress.<\/h3>\n<\/div>\n<\/div>\n<div class=\"col-md-auto\">\n<div class=\"more\"><a class=\"btn btn-primary btn-radius\" href=\"http:\/\/www.sinotau.com\/en\/category\/company-news\/\">Read More<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"news-list\"><div class=\"swiper newsSliders\"><div class=\"swiper-wrapper\"><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"http:\/\/www.sinotau.com\/en\/2024\/07\/meilleur-a-joint-venture-of-sinotau-that-holds-global-rights-to-nav-4694-an-s-amyloid-pet-imaging-agent-for-alzheimers-disease-is-sold\/\"><h3 class=\"title\">Meilleur, a\u00a0Joint Venture of\u00a0Sinotau, That Holds Global Rights to NAV-4694, an \u00df Amyloid PET Imaging Agent for Alzheimer\u2019s Disease, Is Sold<\/h3><p class=\"des\">Recently,\u00a0Meilleur, a\u00a0joint venture of\u00a0Sinotau, that holds global rights to\u00a0NAV-4694,\u00a0an \u00df amyloid PET imaging agent for Alzheimer\u2019s disease,\u00a0was acquired by Lantheus. Recently published updated guidelines developed by a working group of the National Institute on Aging and the Alzheimer&#8217;s Association (NIA-AA) state that Alzheimer\u2019s disease should be defined biologically, using protein-based biomarkers. These guidelines recommend that [&hellip;]<\/p><div class=\"date\">2024-07-23<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"http:\/\/www.sinotau.com\/en\/2023\/10\/life-molecular-imaging-and-sinotau-pharmaceutical-group-announce-the-regulatory-approval-of-their-amyloid-pet-imaging-radiopharmaceutical-neuraceq-in-china\/\"><h3 class=\"title\">Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid\u00a0PET\u00a0Imaging Radiopharmaceutical Neuraceq\u00ae in China\u00a0\u00a0<\/h3><p class=\"des\">First Amyloid PET Tracer Received Regulatory Approval in China<\/p><div class=\"date\">2023-10-24<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"http:\/\/www.sinotau.com\/en\/2023\/10\/press-conference-on-the-regulatory-approval-of-florbetaben-f18-injection-the-first-beta-amyloid-pet-imaging-radiotracer-in-china-was-held-in-beijing-opening-a-new-hor\/\"><h3 class=\"title\">Press Conference on\u00a0the\u00a0Regulatory\u00a0Approval of Florbetaben F18 Injection , the First Beta Amyloid\u00a0PET\u00a0Imaging Radiotracer in China, Was Held in Beijing, Opening\u00a0a New Horizon for Early, Precise, and Non-invasive Diagnosis of Alzheimer&#8217;s Disease<\/h3><p class=\"des\">Beijing, China, October 17, 2023\u2013\u00a0the Press Conference on the Regulatory\u00a0Approval of Florbetaben F\u00a018 Injection, organized by Sinotau Pharmaceutical Group, the leading company of innovative radiopharmaceuticals in China, was successfully held in Beijing. Co-President Mrs.\u00a0Yanmin\u00a0Tang, Vice President\u00a0and Secretary of the Board of Directors Mr.\u00a0Wenbin\u00a0Yu, Medical Marketing Director Mr.Xin Wang and other senior leaders of the company [&hellip;]<\/p><div class=\"date\">2023-10-18<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"http:\/\/www.sinotau.com\/en\/2023\/10\/sinotau-pharmaceutical-group-and-blue-earth-diagnostics-ltd-collaborate-on-an-agreement-to-bring-an-innovative-psma-targeted-pet-imaging-agent-to-china-paving-the-way-for-integrated-tumor-theranostic\/\"><h3 class=\"title\">Sinotau Pharmaceutical Group and Blue Earth Diagnostics Ltd collaborate on an agreement to bring an innovative PSMA-targeted PET imaging agent to China, Paving the Way for Integrated Tumor Theranostics<\/h3><p class=\"des\">BEIJING, China, 17 October 2023 &#8211;\u00a0Sinotau Pharmaceutical Group and the British molecular imaging company Blue Earth Diagnostics\u00a0Ltd\u00a0are announcing\u00a0an exclusive strategic agreement for the development, production, and commercialization of the innovative PSMA-targeted PET imaging agent flotufolastat\u00a0(18F)\u00a0in China. Flotufolastat&nbsp;(18F)&nbsp;is an optimized positron emission tomography (PET) imaging agent designed to target prostate-specific membrane antigen (PSMA) positive lesions, indicated [&hellip;]<\/p><div class=\"date\">2023-10-17<\/div><\/a><\/div><div class=\"swiper-slide\"><a class=\"item wow fadeInUp\" href=\"http:\/\/www.sinotau.com\/en\/2023\/09\/sinotau-presents-new-products-at-the-2023-academic-annual-meeting-of-the-chinese-society-of-nuclear-medicine\/\"><h3 class=\"title\">Sinotau Presents New Products at the 2023 Academic Annual Meeting of the Chinese Society of Nuclear Medicine<\/h3><p class=\"des\">BEIJING,&nbsp;China, 21-23&nbsp;September&nbsp;2023 &#8211;&nbsp;The 2023 Academic Annual Meeting of the Chinese Society of Nuclear Medicine was successfully held in the ancient capital Xi&#8217;an, where&nbsp;experts and scholars in nuclear medicine and related fields, excellent companies and industry elites gathered together. As a leading company of innovative radiopharmaceuticals, Sinotau also participated in this event. The conference was organized [&hellip;]<\/p><div class=\"date\">2023-09-24<\/div><\/a><\/div><\/div><div class=\"swiper-pagination\"><\/div><\/div><\/div>\n<\/div>\n<\/div>\n\n\n<section class=\"page page-home-s5 pt-media-9 pb-media-9\">\n<div class=\"container\">\n<div class=\"job wow fadeInLeft\">\n<h4 class=\"sub_title\">Talent Development<\/h4>\n<div class=\"des text32 mb-media-3\">We hope to <strong>invent radiopharmaceuticals for lives<\/strong> with you following the same <strong>heart and ideal<\/strong>. It&#8217;s a job, and moreover, it&#8217;s common endeavour.<\/div>\n<div class=\"go\"><a href=\"http:\/\/www.sinotau.com\/en\/join\/\">Join Us<i class=\"iconfont icon-right\"><\/i><\/a><\/div>\n<\/div>\n<\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>Invent radiopharmaceuticals for lives Lays out oncology , neurology and cardiology Products Who We Are? A company ahead of the innovative radiopharmaceuticals in China. Since 2014, Sinotau started the R&amp;D of next-generation radiopharmaceuticals,which is an innovative pharmaceutical company specializing in the R&amp;D, production, clinical application and marketing of radiopharmaceuticals About Sinotau 9 Year+ Years of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-3626","page","type-page","status-publish","hentry"],"meta_box":{"salary":[],"career":[]},"_links":{"self":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/comments?post=3626"}],"version-history":[{"count":43,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626\/revisions"}],"predecessor-version":[{"id":4643,"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/pages\/3626\/revisions\/4643"}],"wp:attachment":[{"href":"http:\/\/www.sinotau.com\/en\/wp-json\/wp\/v2\/media?parent=3626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}